Borut Cizman Selected Research

GSK1278863

1/2023	Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
1/2023	The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease.
1/2022	Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
1/2022	Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
12/2021	Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
12/2021	Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
10/2019	Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure.
2/2019	Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.
2/2019	Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis.
7/2018	An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Borut Cizman Research Topics

Disease

11	Chronic Renal Insufficiency 01/2023 - 07/2003
10	Anemia 01/2022 - 07/2018
8	Hypoxia (Hypoxemia) 01/2023 - 07/2018
3	Heart Failure 01/2023 - 11/2018
3	Myocardial Infarction 12/2021 - 11/2018
3	Stroke (Strokes) 12/2021 - 11/2018
3	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 11/2002
1	Fatigue 01/2023
1	Iron Deficiencies 09/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Solitary Kidney 04/2008
1	Abdominal Aortic Aneurysm 04/2008
1	Renal Artery Obstruction (Renal Artery Stenosis) 04/2008
1	Neoplasms (Cancer) 04/2008
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2006
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2006
1	Multiple Myeloma 11/2002
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2002
1	Lymphadenopathy 08/2002
1	Nephritis 08/2002

Drug/Important Bio-Agent (IBA)

10	GSK1278863IBA 01/2023 - 07/2018
9	Prolyl-Hydroxylase InhibitorsIBA 01/2023 - 07/2018
9	Hemoglobins (Hemoglobin)IBA 01/2023 - 07/2018
6	HematinicsIBA 01/2023 - 11/2018
3	Darbepoetin alfa (Aranesp)FDA Link 01/2022 - 12/2021
3	Erythropoietin FDA Link 12/2021 - 07/2018
2	omega-Chloroacetophenone (Mace)IBA 12/2021 - 06/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	Transferrin (beta 2 Transferrin)IBA 01/2023
1	Angiotensin Receptor AntagonistsIBA 01/2023
1	Epoetin Alfa (Epogen)FDA Link 01/2022
1	Parathyroid Hormone (Parathormone)IBA 09/2020
1	IronIBA 10/2019
1	Phosphates (Orthophosphate)IBA 07/2003
1	ParaproteinsIBA 11/2002
1	Saline SolutionIBA 11/2002
1	Phosphorus (Red Phosphorus)IBA 11/2002
1	AutoantibodiesIBA 08/2002
1	Immunoglobulin G (IgG)IBA 08/2002
1	AntigensIBA 08/2002

Therapy/Procedure

6	Therapeutics 10/2022 - 07/2003
3	Renal Dialysis (Hemodialysis) 02/2019 - 11/2002
1	Blood Transfusion (Blood Transfusions) 10/2019
1	Stents 04/2008
1	Radiofrequency Ablation 04/2008
1	Cell Transplantation 07/2006